The global Necrotizing Enterocolitis (NEC) Drugs Market is witnessing steady growth due to the rising incidence of preterm births and neonatal complications. Key developments in probiotics, anti-inflammatory agents, and microbiome-modulating therapies are accelerating innovation in this space, with strong demand emerging from NICUs and pediatric care centers. https://www.datamintelligence.com/research-report/phosphoglucomutase-deficiency-market